High-concentration monoclonal antibodies (mAbs) are gaining prominence given the...
Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for ...
The Cardiovascular and Renal Drugs Advisory Committee voted 10-6 in support of S...
Plaque psoriasis is a chronic condition that affects millions yet is often misun...
The US FDA approved Itovebi in combination with Pfizer’s Ibrance and AstraZeneca...
City Therapeutics has announced its launch accompanied by a $135m Series A finan...
Ipsen has received the UK MHRA's approval for its Elafibranor (Iqirvo) for the t...
In this issue: The manufacturing shift to meet growing cell and gene therapy dem...
Emergent said it is separately working on increasing the availability of its ove...
As a major report highlights the challenges of a struggling NHS, the call for pr...
The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaem...
Purespring Therapeutics has raised $105m in a Series B funding round which will ...
Discover the leading Clinical Dose Companies in Contract Manufacturing. Download...
The company employs machine learning to uncover disease mechanisms at the mRNA l...
The deal allows MSD to license one or more therapies against inflammatory diseas...
mRNA-based vaccines, which instruct cells to produce proteins that can prevent o...
